Free Trial

Universal Health Services (UHS) Stock Forecast & Price Target

Universal Health Services logo
$182.60 -1.56 (-0.85%)
(As of 12/17/2024 ET)

Universal Health Services - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
7
Buy
9

Based on 16 Wall Street analysts who have issued ratings for Universal Health Services in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 16 analysts, 7 have given a hold rating, 8 have given a buy rating, and 1 has given a strong buy rating for UHS.

Consensus Price Target

$226.14
23.85% Upside
According to the 16 analysts' twelve-month price targets for Universal Health Services, the average price target is $226.14. The highest price target for UHS is $274.00, while the lowest price target for UHS is $193.00. The average price target represents a forecasted upside of 23.85% from the current price of $182.60.
Get the Latest News and Ratings for UHS and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Universal Health Services and its competitors.

Sign Up

UHS Analyst Ratings Over Time

TypeCurrent Forecast
12/19/23 to 12/18/24
1 Month Ago
11/19/23 to 11/18/24
3 Months Ago
9/20/23 to 9/19/24
1 Year Ago
12/19/22 to 12/19/23
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
8 Buy rating(s)
9 Buy rating(s)
8 Buy rating(s)
6 Buy rating(s)
Hold
7 Hold rating(s)
6 Hold rating(s)
5 Hold rating(s)
7 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$226.14$231.14$224.92$156.36
Forecasted Upside23.85% Upside16.76% Upside-5.39% Downside3.62% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Hold

UHS Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

UHS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Universal Health Services Stock vs. The Competition

TypeUniversal Health ServicesMedical CompaniesS&P 500
Consensus Rating Score
2.63
2.81
2.51
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside23.85% Upside28,675.54% Upside12.02% Upside
News Sentiment Rating
Positive News

See Recent UHS News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/17/2024JPMorgan Chase & Co.
3 of 5 stars
 Reiterated RatingNeutral$226.00+22.76%
12/16/2024The Goldman Sachs Group
2 of 5 stars
J. Perse
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$228.00 ➝ $198.00+5.66%
11/26/2024TD Cowen
5 of 5 stars
R. Langston
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$275.00 ➝ $251.00+24.25%
11/25/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$285.00 ➝ $230.00+15.54%
11/6/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral$223.00+5.16%
10/28/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetSector Perform ➝ Sector Perform$222.00 ➝ $211.00+3.38%
10/25/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Mok
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$256.00 ➝ $271.00+33.02%
10/25/2024Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$219.00 ➝ $219.00+6.77%
10/11/2024KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Gillmor
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageSector Weight
9/4/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$236.00 ➝ $274.00+15.93%
8/14/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$247.00 ➝ $267.00+20.71%
7/25/2024Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingEqual Weight ➝ Equal Weight$200.00 ➝ $200.00-2.28%
6/26/2024Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Ha
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
4/12/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$208.00 ➝ $203.00+21.98%
3/6/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$175.00 ➝ $200.00+13.96%
2/29/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$170.00 ➝ $193.00+17.48%
7/27/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$163.00 ➝ $169.00+19.49%
6/2/2023VNET Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingAssumes
5/26/2023SVB Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeMarket Perform ➝ Outperform$147.00 ➝ $170.00+32.83%
5/8/2023888
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
3/1/2023Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Peer Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 09:18 AM ET.


UHS Forecast - Frequently Asked Questions

According to the research reports of 16 Wall Street equities research analysts, the average twelve-month stock price forecast for Universal Health Services is $226.14, with a high forecast of $274.00 and a low forecast of $193.00.

16 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Universal Health Services in the last year. There are currently 7 hold ratings, 8 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" UHS shares.

According to analysts, Universal Health Services's stock has a predicted upside of 23.85% based on their 12-month stock forecasts.

Over the previous 90 days, Universal Health Services's stock had 1 upgrade and 1 downgrade by analysts.

Universal Health Services has been rated by research analysts at Bank of America, Barclays, Cantor Fitzgerald, JPMorgan Chase & Co., KeyCorp, Royal Bank of Canada, TD Cowen, The Goldman Sachs Group, and Wells Fargo & Company in the past 90 days.

Analysts like Universal Health Services less than other "medical" companies. The consensus rating score for Universal Health Services is 2.63 while the average consensus rating score for "medical" companies is 2.81. Learn more on how UHS compares to other companies.


This page (NYSE:UHS) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners